Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
|Articles|January 2, 2015
- Pharmaceutical Technology-01-02-2015
- Volume 39
- Issue 1
Ross Charging Hopper Increases Efficiency
Ross’ high-efficiency charging hopper for High Shear Mixers with Solids/Liquid Injection Manifold (SLIM) Technology is designed for high-speed powder injection into liquids and eliminates the need for eductors or pumps. The design improves the rate of feed delivery at a steady pace and prevents the bridging of bulk solids, which include: fumed silica, CMC, guar gum, carbon black, carrageenan, xanthan gum, talc, alginates, pectin, titanium dioxide, calcium carbonate, starch, clays, alumina, carbomers, sugar, salts, and dye powders.
The 30HP SLIM mixer is equipped with three level transmitters and a solenoid-operated multi-position modulating valve to maintain a liquid flow rate within 80% to 100% of the 500 gpm design flow rate. All contact parts are made of stainless steel 316 polished to 150-grit (32 Ra) finish.
Ross, Charles & Son Company
Article DetailsPharmaceutical Technology
Vol. No. 1
Page: 14
Articles in this issue
almost 12 years ago
Value-Based Healthcare in the: United Kingdomalmost 12 years ago
Mitigating Risk for Single-Use Assemblies in Sterile Fillingalmost 12 years ago
Building a Barrier in Solid-Dosage Drug Packagingalmost 12 years ago
Using Tocophersolan for Drug Deliveryalmost 12 years ago
Industry Expert Q&A with Fred Miesowiczalmost 12 years ago
Innovative Excipients in Solid-Dosage Manufacturingalmost 12 years ago
Great Expectations from New European Commissionalmost 12 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsalmost 12 years ago
Standards Organizations Updatealmost 12 years ago
Politics and Patients to Shape Pharma in 2015Related to this article
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech's biggest takeaways.
The FDA approves asundexian, the first factor XIa inhibitor, cutting stroke risk 26% and setting a regulatory benchmark for factor XI drug developers.
Panelists on the PharmTech AI Pulse Check weigh a December AI playbook, EMA/MHRA moves, PCCP accountability gaps, and MCP-ready regulatory guidance.
Trending on Pharmaceutical Technology
1
Pimicotinib TGCT Approval Shows How Assessment Aid Supports Review
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
4
Drapeau’s AI Deep Dive: Qualify the Reviewer Before the AI Goes Live
5